Average Insider

Where insiders trade, we follow

AbCellera Biologics Inc. ($ABCL)
Booth Andrew โ€“ Chief Financial Officer
Aug 14, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$2.75
Current$11.3898.6% above low, 1.4% below high
Purchase$10.3286.5% above low, 13.5% below high
52W High$11.50
Shares
37,200
Price
$10.32
Total Value
$383,904.00
P&L
+10.3% (+$39,432.00)

Nearby Earnings

Aug 5, 2026
EPS:-0.18 (est: -0.16)+9.8%
Revenue:$4.05M (est: $7.85M)-48.4%
Aug 6, 2026
EPS:Est: -0.17
Revenue:Est: $7.85M

Transaction Details

InsiderBooth Andrew
TitleChief Financial Officer
Transaction DateAug 14, 2026
Transaction CodeP Purchase
Acquired/DisposedAcquired
Security
Common Shares
Direct/IndirectDirect
Filing DateAug 14, 2026
Shares Purchased37,200
Price per Share$10.32
Total Value$383,904.00
Shares Owned After482,800
DerivativeNo
Accession Number0001834411-26-000008
DocumentView SEC Filing
Version: v26.7.3